-
- Research/Project Funding Opportunity
- Posted 1 month ago
Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (R41/R42 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 month ago
Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (R43/R44 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
at Department of Health and Human Services National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Preventing Youth Overdose: Treatment, Recovery, Education, Awareness and Training
at Department of Health and Human Services Substance Abuse and Mental Health Services Adminis in United States -
- Financial Aid Offer
- Posted 1 year ago
Provider’s Clinical Support System – Medications for Alcohol Use Disorders
at Department of Health and Human Services Substance Abuse and Mental Health Services Adminis in United States -
- Financial Aid Offer
- Posted 1 year ago
Provider’s Clinical Support System – Medications for Opioid Use Disorder
at Department of Health and Human Services Substance Abuse and Mental Health Services Adminis in United States -
- Fellowship
- Posted 1 year ago
Medication-Assisted Treatment – Prescription Drug and Opioid Addiction
at Department of Health and Human Services Substance Abuse and Mental Health Services Adminis in United States -
- Research/Project Funding Opportunity
- Posted 4 years ago
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
at Department of Health and Human Services National Institutes of Health in United States